Bombay College of Pharmacy: Admission 2025, Courses, Fees, Ranking & Mumbai Suburban Campus Life

Bombay College of Pharmacy, Mumbai ranks among India's leading institutions for pharmaceutical education. Established in 1957 by the Indian Pharmaceutical Association, it operates as a Government-Aided Autonomous Institution affiliated with the University of Mumbai, building a strong legacy in pharmaceutical sciences. The college offers a diverse range of programs across undergraduate, postgraduate, and doctoral levels, including the highly regarded Bachelor of Pharmacy and Master of Pharmacy with various specializations, along with PhD programs. Admission to these programs is primarily through competitive entrance exams like MHT CET, NEET, GPAT, and PET, based on merit. BCP Mumbai has received recognition through rankings such as the NIRF, where it was ranked 73rd in the Pharmacy category in 2024. It is approved by AICTE and PCI and accredited by NBA. The institution is committed to quality education and research, evident in its experienced faculty and well-equipped laboratories. The campus provides a conducive learning environment with essential infrastructure spread across 4 acres. Facilities include a library, modern classrooms, labs, and provisions for sports and recreation. While specific data on total student enrollment varies, recent figures suggest around 540 students with a faculty-student ratio of 1:12. The college maintains a gender ratio favouring female students. Career outcomes are a key focus, with an active placement cell facilitating opportunities in leading pharmaceutical companies. The college boasts strong placement records for its graduates across UG, PG, and PhD levels, with graduates finding roles in industry, research, and academia. The institution also engages in collaborations, including those with international research institutes, enhancing global exposure for students. Overall, Bombay College of Pharmacy is recognized for its academic rigour, industry relevance, and contribution to the pharmaceutical sector.